Part 1: Early Recognition and Intervention in Cancer Cachexia

Welcome to part one of a three-part episode entitled, Early Recognition and Intervention in Cancer Cachexia: Pathophysiology, Diagnosis, and Management. Cancer cachexia is a progressive muscle-wasting syndrome that significantly diminishes the quality of life for many patients with cancer. For part one, we are joined by Professor Aminah Jatoi, who will talk about the latest advances in early recognition and current standard of care in cancer cachexia and share management strategies for informing patients and their care providers. 

This discussion was originally broadcast as an ACCME-accredited webinar entitled, Early Recognition and Intervention in Cancer Cachexia: Pathophysiology, Diagnosis, and Management, delivered by Professor Aminah Jatoi, Professor Jeffrey Crawford and Dr Rony Dev. It was published as part of the American Cancer Society - Cancer Cachexia Knowledge Hub educational program. To claim 1.0 AMA PRA Category 1TM credit for this episode, along with parts two and three, please visit https://cancercachexia.knowledgehub.wiley.com/webinars/early-recognition-and-intervention-in-cancer-cachexia/. The Knowledge Hub also contains additional educational materials on cancer cachexia, including conference highlights from AACR 2025, ASCO 2025, ASCO GI 2026, ESMO 2025, SCWD 2024 and 2025 as well as additional resources such as practical case studies and downloadable infographics. 

The Cancer Cachexia Knowledge Hub program is supported by an educational grant from Pfizer. 

Speaker - Professor Aminah Jatoi, MD. Betty J. Foust, MD and Parents' Professor of Oncology, Mayo Clinic, Rochester, Minnesota. Full speaker biography - https://cancercachexia.knowledgehub.wiley.com/faculty/  

For more medical education from Wiley, please visit https://focus.wiley.com/